{"gene":"APOBEC1","run_date":"2026-04-28T17:12:37","timeline":{"discoveries":[{"year":1995,"finding":"APOBEC1 contains distinct functional domains: a zinc-coordinating catalytic domain (H61, E63, C93, C96) required for cytidine deaminase activity and apoB RNA editing, a leucine-rich region (LRR) required for RNA editing but not deaminase activity, and an RNA-binding domain; mutation of H61→Arg abolishes RNA binding while E63→Gln and C96→Ser mutants retain RNA binding but lose editing activity. Overexpression acts as a dominant negative when RNA binding is eliminated.","method":"Site-directed mutagenesis of GST-APOBEC1 fusion protein, in vitro cytidine deaminase assays, UV cross-linking RNA binding assays, transient transfection in McA 7777 cells","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — reconstitution with mutagenesis of multiple catalytic residues, orthogonal functional assays","pmids":["7782343"],"is_preprint":false},{"year":1995,"finding":"Recombinant APOBEC1 binds with high specificity to apoB RNA in AU-rich sequences, demonstrated by UV cross-linking and EMSA; binding is competed by poly(U) and poly(A,U) but not poly(A); binding specificity for the RNA template is distinct from editing specificity.","method":"UV cross-linking, electrophoretic mobility shift assay (EMSA), RNA competition assays with recombinant GST-APOBEC1","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with multiple orthogonal methods","pmids":["7782342"],"is_preprint":false},{"year":1996,"finding":"Targeted disruption of mouse apobec-1 abolishes all apoB mRNA editing and eliminates apoB48 production in all tissues, demonstrating APOBEC1 is the essential catalytic subunit with no functional gene duplication.","method":"Gene targeting/knockout mice, apoB mRNA editing assay, Western blot for apoB48","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — clean knockout with defined molecular phenotype, replicated by second independent KO study","pmids":["8626621","8824235"],"is_preprint":false},{"year":1996,"finding":"Overexpression of APOBEC1 in stable rat hepatoma cell lines results in promiscuous RNA editing of cytidines 5' of the mooring sequence in addition to the wild-type site, and this promiscuous editing is mooring sequence-dependent and increases with APOBEC1 expression level.","method":"Stable cell lines overexpressing APOBEC1, apoB RNA editing assays, sequence analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — cell-based overexpression with clear dose-response and defined molecular readout","pmids":["8621694"],"is_preprint":false},{"year":1996,"finding":"APOBEC1 requires a 65-kDa complementing protein (later identified as ACF) for apoB mRNA editing activity in vitro; this protein interacts directly with APOBEC1 in the absence of apoB mRNA, as demonstrated by APOBEC1 affinity chromatography.","method":"Affinity chromatography using immobilized recombinant His6-APOBEC1, size exclusion chromatography, glycerol gradient sedimentation, functional in vitro editing assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — biochemical reconstitution with purified components, direct pulldown","pmids":["8910449"],"is_preprint":false},{"year":1997,"finding":"APOBEC1 functions as a homodimer; a catalytically inactive mutant (H61K/C93S/C96S) that retains dimerization capacity acts as a dominant negative inhibitor of wild-type APOBEC1 editing activity in vivo, while mutants that dimerize poorly do not inhibit.","method":"In vitro editing assay, co-immunoprecipitation of epitope-tagged APOBEC1 mutants, adenoviral delivery to mice","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — reciprocal co-IP plus in vitro assay plus in vivo validation","pmids":["8999814"],"is_preprint":false},{"year":1997,"finding":"ABBP-1, an hnRNP-type RNA-binding protein, interacts with APOBEC1 via its glycine-rich C-terminal domain and binds apoB mRNA; immunodepletion of ABBP-1 from editing extracts inhibits editing activity.","method":"Yeast two-hybrid screening, deletion mapping, UV cross-linking, immunodepletion, antisense knockdown in HepG2 cells","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 3 — yeast two-hybrid plus immunodepletion, single lab","pmids":["8999813"],"is_preprint":false},{"year":1999,"finding":"APOBEC1 exhibits a consensus high-affinity binding site for AU-rich RNA of sequence UUUN[A/U]U; binding to the c-myc 3'UTR containing this motif stabilizes c-myc mRNA (half-life increased from 90 to 240 min), an effect dependent on APOBEC1 RNA-binding activity.","method":"Filter binding assays, circular-permutation analysis, actinomycin D mRNA turnover assays in transfected F442A cells with RNA-binding mutants","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 — binding site defined biochemically, functional mRNA stabilization confirmed with RNA-binding mutant controls","pmids":["10688645"],"is_preprint":false},{"year":2000,"finding":"ACF (apobec-1 complementation factor), a 65-kDa protein with three RNA recognition motifs, is identified as the obligate RNA-binding subunit of the minimal apoB mRNA editing holoenzyme; ACF binds the mooring sequence of apoB mRNA, interacts with APOBEC1, and together they constitute the minimal editing complex.","method":"Protein purification, peptide sequencing, molecular cloning, UV cross-linking, co-immunoprecipitation, immunodepletion from liver extracts, in vitro reconstitution of editing","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 — reconstituted minimal holoenzyme in vitro, multiple orthogonal methods, immunodepletion","pmids":["10669759"],"is_preprint":false},{"year":2000,"finding":"GRY-RBP is an apoB RNA-binding protein that interacts with both APOBEC1 and ACF; it competitively inhibits ACF binding to apoB mRNA and C-to-U editing by sequestering ACF, and antisense knockdown of GRY-RBP increases apoB RNA editing.","method":"Two-hybrid screening, recombinant protein pulldowns, RNA binding assays, immunodepletion, antisense oligonucleotide knockdown, confocal colocalization","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods including reconstitution, competition assays, and knockdown","pmids":["11134005"],"is_preprint":false},{"year":2000,"finding":"APOBEC1-mediated apoB mRNA editing can occur in the cytoplasm when APOBEC1 is overexpressed; under normal conditions editing is restricted to the nucleus. ACF distributes to both nucleus and cytoplasm, providing auxiliary protein support in both compartments.","method":"Reporter RNA assays with intron-containing constructs, immunolocalization of ACF and APOBEC1 in McArdle cells, ethanol stimulation experiments","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — functional editing assay combined with immunolocalization, single lab","pmids":["10833526"],"is_preprint":false},{"year":2001,"finding":"CUGBP2, a 54-kDa RNA-binding protein, is a component of the apoB mRNA editing holoenzyme; it co-fractionates with ACF, binds apoB RNA upstream of the edited cytidine, and dose-dependently inhibits C-to-U editing in a reconstituted system, rescued by addition of APOBEC1 or ACF.","method":"Co-fractionation, co-immunoprecipitation, RNA binding assays, reconstituted editing system, antisense knockdown","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods with reconstitution and knockdown confirmation","pmids":["11577082"],"is_preprint":false},{"year":2001,"finding":"ARCD-1, an apobec-1 homologue, heterodimerizes with both APOBEC1 and ACF, exhibits cytidine deaminase and apoB RNA binding activity but cannot catalyze C-to-U RNA editing; it acts as a dominant negative inhibitor of APOBEC1-mediated editing.","method":"Co-immunoprecipitation, in vitro editing assays, cytidine deaminase assays, subcellular localization by immunofluorescence","journal":"American journal of physiology. Cell physiology","confidence":"Medium","confidence_rationale":"Tier 2 — co-IP plus functional assays, single lab","pmids":["11698249"],"is_preprint":false},{"year":2001,"finding":"ABBP-2, a DnaJ/Hsp40 family protein, binds APOBEC1 via its J domain and neighboring G/F domain; Hsp70/ABBP-2 interaction (requiring ATP) is necessary for apoB mRNA editing activity in vitro extracts, and ABBP-2 knockdown inhibits endogenous editing.","method":"Yeast two-hybrid, co-immunoprecipitation, in vitro editing assays with ATP depletion, ATPase stimulation assays, antisense knockdown","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — multiple binding and functional assays, single lab","pmids":["11584023"],"is_preprint":false},{"year":2001,"finding":"ACF localizes predominantly to the nucleus; the NH2-terminal 380 residues containing RNA recognition motifs define both apoB RNA binding and APOBEC1-interacting domains. ACF cotransfection with APOBEC1 results in nuclear colocalization and nuclear import of APOBEC1 via protein-protein interaction.","method":"Deletion mutagenesis, co-immunoprecipitation, RNA binding assays, confocal microscopy, transfection","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — systematic domain mapping with multiple orthogonal methods and functional validation","pmids":["11571303"],"is_preprint":false},{"year":2002,"finding":"APOBEC1 and its homologs APOBEC3C and APOBEC3G exhibit potent DNA mutator activity in an E. coli assay through dC deamination, with each protein showing distinct local target sequence specificity.","method":"E. coli rifampicin resistance mutation assay, sequence analysis of mutations","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 2 — robust bacterial assay, replicated across multiple family members with sequence specificity characterization","pmids":["12453430"],"is_preprint":false},{"year":2002,"finding":"ACF requires N-terminal pre-RRM regions and all three RRMs for apoB mRNA binding and complementing activity; the RG-rich auxiliary domain is required for apobec-1 interaction and complementing activity; RRM1 and RRM2 mutations reduce binding affinity by 100-fold while RRM3 reduces it 13-fold.","method":"Deletion mutagenesis, point mutagenesis, RNA binding assays measuring Kd, in vitro complementation editing assays","journal":"RNA (New York, N.Y.)","confidence":"High","confidence_rationale":"Tier 1 — systematic mutagenesis with quantitative binding measurements and functional complementation assays","pmids":["11871661"],"is_preprint":false},{"year":2003,"finding":"APOBEC1 can deaminate cytosine to uracil in single-stranded DNA in vitro, with activity dependent on local sequence context; this establishes APOBEC1 as a dual RNA and DNA cytosine deaminase.","method":"In vitro deamination assay using partially purified APOBEC1 from E. coli with ssDNA substrates","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — direct in vitro biochemical assay demonstrating DNA deamination activity","pmids":["12697753"],"is_preprint":false},{"year":2003,"finding":"A novel 41-residue motif (ANS) in the auxiliary domain of ACF functions as an authentic nuclear localization signal; ACF nuclear accumulation is transcription-dependent and reversible, and ACF shuttles between nucleus and cytoplasm via binding to the carrier protein transportin 2.","method":"GFP/beta-gal chimera localization, actinomycin D treatment, leptomycin B (CRM1 inhibitor), heterokaryon assays, co-immunoprecipitation with transportin 2, confocal microscopy","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal localization methods plus mechanistic identification of nuclear import carrier","pmids":["12896982"],"is_preprint":false},{"year":2004,"finding":"Crystal structure of yeast CDD1 (APOBEC1 ortholog) at 2.0 Å reveals a central active site 'flap' that accommodates large substrates (RNA or DNA) and models of APOBEC1 and AID suggest both are equally likely to bind ssDNA or RNA; the structure explains dimerization and need for trans-acting loops in active site formation.","method":"X-ray crystallography at 2.0 Å, comparative structural modeling of APOBEC1 and AID","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — crystal structure with functional interpretation via comparative modeling","pmids":["15148397"],"is_preprint":false},{"year":2004,"finding":"Apobec-1 binds AU-rich sequences in the 3'UTR of cyclooxygenase-2 (COX-2) mRNA and stabilizes it; deletion of apobec-1 in mice reduces COX-2 mRNA stabilization after irradiation, reducing intestinal stem cell survival through loss of prostaglandin E2-mediated radioprotection.","method":"EMSA, UV cross-linking with recombinant APOBEC1, luciferase-COX-2 3'UTR reporter assays, apobec-1 knockout mice with gamma irradiation, clonogenic intestinal crypt survival assay","journal":"Gastroenterology","confidence":"High","confidence_rationale":"Tier 2 — direct RNA binding demonstrated biochemically, functional consequence validated with KO mice and defined readout","pmids":["15480992"],"is_preprint":false},{"year":2004,"finding":"APOBEC1 apoenzyme alone has residual editing activity on minimal apoB mRNA substrate without auxiliary factors; ACF broadens the temperature range of APOBEC1 activity and lowers the optimal temperature, likely by promoting a conformational transition in the RNA substrate.","method":"In vitro editing assays with purified recombinant APOBEC1, optimization by incomplete factorial and response surface experiments, steady-state kinetic analysis with and without ACF","journal":"RNA (New York, N.Y.)","confidence":"High","confidence_rationale":"Tier 1 — reconstituted in vitro system with purified components and kinetic analysis","pmids":["15273326"],"is_preprint":false},{"year":2005,"finding":"NMR structure of the 31-nt apoB mRNA stem-loop reveals the edited C6666 is stacked in an octa-loop; APOBEC1 alone does not specifically bind apoB mRNA and requires ACF for specific editing; ACF recognizes the flexible mooring sequence and then melts the stem-loop to expose C6666 for deamination.","method":"NMR structure determination of apoB mRNA stem-loop, RNA binding assays with APOBEC1 and ACF","journal":"RNA (New York, N.Y.)","confidence":"High","confidence_rationale":"Tier 1 — NMR structure plus functional binding assays defining mechanism of substrate recognition","pmids":["15659357"],"is_preprint":false},{"year":2006,"finding":"ACF is a metabolically regulated phosphoprotein; serine phosphorylation of ACF (by protein phosphatase I-sensitive kinase) is restricted to nuclear extracts where it co-sediments with editing-competent 27S complexes; ethanol stimulation of editing is associated with 2-3 fold increased ACF phosphorylation; alkaline phosphatase treatment reduces APOBEC1 co-immunoprecipitation with ACF and inhibits editing.","method":"Co-immunoprecipitation, alkaline phosphatase treatment, 2D phosphoamino acid analysis, protein phosphatase inhibitors, metabolic stimulation experiments","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal biochemical methods demonstrating phosphorylation regulates editosome assembly","pmids":["16820530"],"is_preprint":false},{"year":2006,"finding":"PKC phosphorylates ACF at S154 and S368; S154A/S368A mutations inhibit ethanol-stimulated editing while S154D/S368D phosphomimetic mutations stimulate editing to levels comparable to ethanol treatment; PKA has no effect on editing or ACF phosphorylation.","method":"In vitro phosphorylation with purified kinases, site-directed mutagenesis, editing assays in primary hepatocytes and McArdle cells","journal":"Biochimica et biophysica acta","confidence":"High","confidence_rationale":"Tier 1 — in vitro kinase assay plus mutagenesis with functional readout","pmids":["17229474"],"is_preprint":false},{"year":2006,"finding":"APOBEC1 and AID are nucleo-cytoplasmic shuttling proteins, whereas APOBEC3G is strongly retained in the cytoplasm through mechanisms involving both N- and C-terminal regions.","method":"Nucleo-cytoplasmic shuttling assays, subcellular fractionation, domain deletion analysis","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 — direct localization experiments with domain mapping, single lab","pmids":["16999936"],"is_preprint":false},{"year":2009,"finding":"APOBEC1 binds AU-rich sequences in the 3'UTR of Cyp7a1 mRNA (containing UUUN[A/U]U consensus motif) as demonstrated by UV cross-linking and in vivo RNA co-immunoprecipitation, and post-transcriptionally regulates Cyp7a1 expression; apobec-1 deletion decreases Cyp7a1 mRNA without altering transcription, increasing gallstone susceptibility.","method":"UV cross-linking with recombinant APOBEC1, in vivo RNA co-immunoprecipitation, apobec-1 knockout mice, adenoviral rescue, hepatocyte nuclear transcription assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — direct RNA binding demonstrated biochemically plus in vivo validation with KO and rescue","pmids":["19386592"],"is_preprint":false},{"year":2011,"finding":"APOBEC1 edits 32 previously undescribed mRNA targets located in AU-rich segments of transcript 3'UTRs, as identified by transcriptome-wide comparative RNA sequencing of APOBEC1-expressing versus control cells.","method":"Comparative RNA-Seq (transcriptome-wide), Sanger sequencing validation","journal":"Nature structural & molecular biology","confidence":"High","confidence_rationale":"Tier 2 — genome-wide approach with Sanger validation, reveals novel substrate class","pmids":["21258325"],"is_preprint":false},{"year":2011,"finding":"APOBEC1 restricts LINE-1 retrotransposition through a deamination-independent mechanism, and inhibits LTR retrotransposons (IAP, MusD) through a mechanism requiring deaminase activity, as demonstrated in cell culture retrotransposition assays.","method":"Cell culture-based retrotransposition assays with wild-type and catalytic mutant APOBEC1, subcellular localization analysis","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 — functional cell-based assays with deaminase-dead mutant controls distinguishing two mechanisms","pmids":["21398638"],"is_preprint":false},{"year":2014,"finding":"RBM47 is a novel RNA-binding protein that interacts with APOBEC1 and A1CF, can substitute for A1CF in complementing APOBEC1 for C-to-U RNA editing in vitro, and is necessary and sufficient for APOBEC1-mediated editing in vivo as shown by Rbm47-deficient mice with impaired editing.","method":"Co-immunoprecipitation, in vitro editing reconstitution, Rbm47 knockout mice, editing assays","journal":"EMBO reports","confidence":"High","confidence_rationale":"Tier 2 — in vitro reconstitution combined with in vivo KO, multiple labs corroborate","pmids":["24916387"],"is_preprint":false},{"year":2014,"finding":"APOBEC1 expression induces a mutator phenotype in vertebrate cells through direct targeting of genomic DNA; it increases inactivation of a stably inserted reporter gene in chicken cells lacking other AID/APOBEC proteins and increases imatinib-resistant clones in a human CML model through BCR-ABL1 mutations.","method":"Reporter gene inactivation assay in DT40 chicken cells, imatinib resistance clonogenic assay in human CML cells, sequence analysis of mutations","journal":"Genome biology","confidence":"High","confidence_rationale":"Tier 2 — multiple cell-based functional assays with sequence-level mechanistic evidence","pmids":["25085003"],"is_preprint":false},{"year":2014,"finding":"Genome-wide deep sequencing identifies 56 novel Apobec-1-dependent C-to-U editing sites in intestinal mRNAs and 22 in liver mRNAs, all in 3'UTRs; editing changes lead to corresponding changes in mRNA and protein levels for 11 genes; cell-free editing validated by wild-type but not Apobec-1-deficient mouse extracts.","method":"Deep RNA sequencing of wild-type and Apobec-1-/- mice, Sanger validation, polysome profiling, cell-free editing assays, adenoviral rescue, transgenic overexpression","journal":"Genome biology","confidence":"High","confidence_rationale":"Tier 2 — genome-wide with multiple validation approaches and mechanistic functional consequences","pmids":["24946870"],"is_preprint":false},{"year":2017,"finding":"A1CF is dispensable for APOBEC1-mediated C-to-U RNA editing in vivo in adult mice; conditional A1cf knockout mice show no changes in RNA editing efficiency for multiple targets including ApoB in intestine, liver, or kidney.","method":"Conditional knockout mice (A1cf floxed allele), RNA editing quantification by sequencing of multiple targets","journal":"RNA (New York, N.Y.)","confidence":"High","confidence_rationale":"Tier 2 — clean conditional KO with systematic quantification of multiple editing targets","pmids":["28069890"],"is_preprint":false},{"year":2017,"finding":"APOBEC1-mediated RNA editing in microglia maintains their resting state; loss of APOBEC1 editing function in microglia leads to progressive age-related neurodegeneration characterized by clustering of activated microglia, aberrant myelination, increased inflammation, and lysosomal anomalies with behavioral and motor deficits.","method":"APOBEC1 editing-deficient mouse model, histological analysis, behavioral assays, protein abundance analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 — KO with defined neurological phenotype, single lab","pmids":["29167375"],"is_preprint":false},{"year":2018,"finding":"A1CF and RBM47 function independently yet interact in a tissue-specific manner to regulate APOBEC1-dependent C-to-U RNA editing; intestinal-specific Rbm47 KO nearly eliminates editing while liver-specific Rbm47 KO reduces a subset; double A1cf/Rbm47 KO in liver eliminates apoB editing and eliminates editing of most targets, beyond the effect of either single KO.","method":"Tissue-specific conditional knockout mice (liver and intestine), RNA editing quantification, adenoviral APOBEC1 administration","journal":"RNA (New York, N.Y.)","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis with multiple tissue-specific double knockouts, systematic editing quantification","pmids":["30309881"],"is_preprint":false},{"year":2020,"finding":"Crystal structure of APOBEC1 reveals a typical APOBEC deaminase core plus a unique well-folded hydrophobic C-terminal domain (A1HD) that forms a stable dimer via hydrophobic interactions creating a four-stranded β-sheet positively charged surface; structure-guided mutagenesis shows A1HD directs RNA and cofactor interactions and governs RNA versus DNA substrate selectivity.","method":"X-ray crystallography, structure-guided mutagenesis, substrate selectivity assays","journal":"NAR cancer","confidence":"High","confidence_rationale":"Tier 1 — crystal structure with mutagenesis validation of functional domains","pmids":["33094286"],"is_preprint":false},{"year":2021,"finding":"RPA (replication protein A) suppresses APOBEC1 cytosine deaminase activity on ssDNA by competing for ssDNA binding; APOBEC1 cannot efficiently compete with RPA in vitro, correlating with low levels of genomic DNA damage in lung cancer cells expressing APOBEC1.","method":"In vitro deamination assays with RPA competition, γH2AX foci measurement in lung cancer cell line","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 — in vitro biochemical assay plus cell-based validation, single lab","pmids":["33330905"],"is_preprint":false},{"year":2014,"finding":"hnRNPQ isoform 6 (hnRNPQ6) is required for efficient interaction of APOBEC1 with IL-8 mRNA; APOBEC1 binding to AU-rich elements in the IL-8 3'UTR extends IL-8 mRNA half-life and increases IL-8 production in a cell type-specific, hnRNPQ6-dependent manner.","method":"RNA co-immunoprecipitation/microarray, mRNA half-life assays, yeast two-hybrid, siRNA screen, luciferase reporter with IL-8 3'UTR","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — multiple assays establishing the hnRNPQ6–APOBEC1–IL8 mRNA ternary interaction, single lab","pmids":["25100733"],"is_preprint":false},{"year":2001,"finding":"C-to-U RNA editing of neurofibromatosis 1 (NF1) mRNA by APOBEC1 occurs preferentially in transcripts containing alternatively spliced exon 23A; adenovirus-mediated APOBEC1 expression in HepG2 cells induces NF1 transcript editing with preference for exon 23A-containing forms, demonstrating APOBEC1 as the catalytic deaminase for this non-apoB target.","method":"In vitro editing assays with recombinant APOBEC1 on synthetic NF1 RNA templates, adenoviral transduction of HepG2 cells, editing quantification by sequencing","journal":"American journal of human genetics","confidence":"Medium","confidence_rationale":"Tier 2 — in vitro and in vivo reconstitution with adenoviral APOBEC1, single lab","pmids":["11727199"],"is_preprint":false}],"current_model":"APOBEC1 is a zinc-dependent cytidine deaminase that functions as the catalytic subunit of a multiprotein RNA editing complex, converting C6666 to U in apoB mRNA (producing apoB48) and editing dozens of additional mRNA targets in 3'UTRs; it requires RNA-binding cofactors—primarily RBM47 (in vivo) and/or A1CF—which bind the mooring sequence and remodel the RNA stem-loop to expose the target cytidine for deamination, while additional regulators (GRY-RBP, CUGBP2, ABBP-1, ABBP-2/Hsp40) modulate holoenzyme assembly; beyond RNA editing, APOBEC1 stabilizes AU-rich mRNAs (COX-2, c-myc, Cyp7a1, IL-8) through direct 3'UTR binding, and can also deaminate cytosines in single-stranded DNA in a sequence-context-dependent manner that is suppressed by RPA, with the homodimeric structure (mediated by the C-terminal hydrophobic domain) and PKC-mediated phosphorylation of ACF regulating editosome assembly and activity."},"narrative":{"teleology":[{"year":1995,"claim":"Defining the catalytic architecture of APOBEC1 established that zinc-coordinating residues (H61, E63, C93, C96) are essential for deaminase activity, a leucine-rich region is required for editing but not deamination, and an RNA-binding domain mediates AU-rich RNA recognition—resolving how a single protein couples substrate binding to catalysis.","evidence":"Site-directed mutagenesis of GST-APOBEC1 with in vitro deaminase, UV cross-linking, and EMSA assays in McA 7777 cells","pmids":["7782343","7782342"],"confidence":"High","gaps":["No three-dimensional structure available at this stage","Cofactor requirements for site-specific editing not yet defined"]},{"year":1996,"claim":"Knockout of Apobec1 in mice abolished all apoB mRNA editing and apoB48 production in every tissue, proving APOBEC1 is the sole essential catalytic subunit with no redundant paralog, while overexpression studies revealed dose-dependent promiscuous editing at additional mooring-sequence-dependent cytidines.","evidence":"Gene targeting in mice with apoB editing and protein assays; stable overexpression in rat hepatoma cells with dose-response editing analysis","pmids":["8626621","8824235","8621694"],"confidence":"High","gaps":["Identity of the obligate cofactor unknown","Mechanism controlling editing fidelity versus promiscuity unresolved"]},{"year":1997,"claim":"Demonstration that APOBEC1 functions as a homodimer—with catalytically inactive dimers acting as dominant negatives—and identification of auxiliary binding partners (ABBP-1) established that editosome assembly involves regulated multimerization.","evidence":"Co-immunoprecipitation of epitope-tagged mutants, adenoviral delivery to mice, yeast two-hybrid and immunodepletion for ABBP-1","pmids":["8999814","8999813"],"confidence":"High","gaps":["Structural basis of dimerization unknown","Stoichiometry and order of assembly not defined"]},{"year":1999,"claim":"Discovery that APOBEC1 binds a UUUN[A/U]U consensus motif in AU-rich 3′ UTRs and stabilizes c-myc mRNA revealed a second, editing-independent function—mRNA stabilization—broadening APOBEC1's biological role beyond site-specific deamination.","evidence":"Filter binding, circular-permutation analysis, actinomycin D chase in transfected F442A cells with RNA-binding mutant controls","pmids":["10688645"],"confidence":"High","gaps":["Full repertoire of stabilized mRNAs unknown","Mechanism distinguishing editing from stabilization unclear"]},{"year":2000,"claim":"Identification of ACF as the obligate RNA-binding cofactor that recognizes the mooring sequence and constitutes, with APOBEC1, the minimal editing holoenzyme resolved the long-standing question of what confers site specificity, while GRY-RBP was shown to negatively regulate editing by sequestering ACF.","evidence":"Protein purification and peptide sequencing, UV cross-linking, co-IP, immunodepletion, in vitro reconstitution; GRY-RBP identified by two-hybrid with competition and knockdown assays","pmids":["10669759","11134005"],"confidence":"High","gaps":["Structural basis of ACF–APOBEC1 interaction unknown","In vivo requirement of ACF versus other cofactors not tested genetically"]},{"year":2001,"claim":"Identification of additional editosome regulators—CUGBP2 as a dose-dependent inhibitor and ABBP-2/Hsp40 as an ATP-dependent activator—demonstrated that the holoenzyme is a dynamically regulated multiprotein assembly, not a simple binary complex; APOBEC1 was also shown to edit NF1 mRNA, extending its target repertoire.","evidence":"Co-fractionation, co-IP, reconstituted editing with purified components, antisense knockdown; NF1 editing by adenoviral APOBEC1 in HepG2 cells","pmids":["11577082","11584023","11727199"],"confidence":"Medium","gaps":["Relative contributions of each auxiliary factor in vivo undetermined","NF1 editing not validated in Apobec1 knockout mice"]},{"year":2003,"claim":"Demonstration that APOBEC1 deaminates cytosines in single-stranded DNA in a sequence-context-dependent manner established it as a dual RNA/DNA deaminase, raising the possibility of genomic mutagenesis.","evidence":"In vitro deamination assay with partially purified APOBEC1 on ssDNA substrates; confirmed in E. coli rifampicin-resistance mutation assay","pmids":["12697753","12453430"],"confidence":"High","gaps":["In vivo relevance of DNA deamination in mammalian cells not yet shown","No structural explanation for dual substrate activity"]},{"year":2005,"claim":"NMR structure of the apoB mRNA stem-loop showed that C6666 is buried in the loop, and ACF melts the stem-loop to expose the target cytidine, providing the first structural mechanism for how cofactor-mediated RNA remodeling enables site-specific editing.","evidence":"NMR structure determination of 31-nt apoB RNA, binding assays with APOBEC1 ± ACF","pmids":["15659357"],"confidence":"High","gaps":["No co-crystal structure of the ternary APOBEC1–ACF–RNA complex","Kinetic mechanism of stem-loop melting not characterized"]},{"year":2006,"claim":"PKC-mediated phosphorylation of ACF at S154 and S368 was shown to regulate editosome assembly and ethanol-stimulated editing, providing a signal transduction mechanism that modulates APOBEC1 activity in response to metabolic cues.","evidence":"In vitro kinase assays, phosphomimetic and phosphodead mutagenesis, editing assays in primary hepatocytes","pmids":["16820530","17229474"],"confidence":"High","gaps":["Upstream signaling pathway linking ethanol to PKC activation not fully defined","Whether phosphorylation regulates ACF shuttling is unknown"]},{"year":2011,"claim":"Transcriptome-wide RNA-Seq revealed dozens of novel APOBEC1-dependent C-to-U editing sites, all in 3′ UTR AU-rich regions, and APOBEC1 was shown to restrict LINE-1 and LTR retrotransposition through partially deamination-independent mechanisms, expanding its functional scope beyond mRNA editing.","evidence":"Comparative RNA-Seq of APOBEC1-expressing vs. control cells with Sanger validation; cell-based retrotransposition assays with catalytic mutants","pmids":["21258325","21398638"],"confidence":"High","gaps":["Functional consequences of most 3′ UTR editing events unknown","Deamination-independent retrotransposon restriction mechanism undefined"]},{"year":2014,"claim":"Identification of RBM47 as a cofactor that is necessary and sufficient for APOBEC1-mediated editing in vivo, and demonstration that APOBEC1 induces genomic DNA mutations in vertebrate cells, resolved two key questions: the in vivo cofactor identity and whether DNA deamination has physiological mutagenic consequences.","evidence":"Rbm47 KO mice with editing quantification plus in vitro reconstitution; reporter gene inactivation in DT40 cells and imatinib resistance assay in CML cells","pmids":["24916387","25085003"],"confidence":"High","gaps":["Relative contribution of RBM47 vs. A1CF across tissues not resolved at this point","Frequency and spectrum of APOBEC1-induced DNA mutations in normal tissues unknown"]},{"year":2017,"claim":"Conditional A1cf knockout mice showed no editing deficiency, demonstrating A1CF is dispensable in vivo, while loss of APOBEC1 editing function in microglia caused progressive neurodegeneration—revealing an unexpected role in maintaining microglial homeostasis.","evidence":"Conditional A1cf KO with systematic editing quantification; APOBEC1 editing-deficient mouse model with histological, behavioral, and inflammatory readouts","pmids":["28069890","29167375"],"confidence":"High","gaps":["Specific mRNA targets mediating the microglial phenotype not identified","Whether RBM47 fully compensates for A1CF loss in all contexts unclear"]},{"year":2018,"claim":"Genetic epistasis with tissue-specific double knockouts of A1cf and Rbm47 demonstrated that these cofactors function independently but collaborate in a tissue-specific manner, with the double KO eliminating apoB editing in liver—clarifying the cofactor hierarchy.","evidence":"Tissue-specific conditional KO mice (liver and intestine) with systematic RNA editing quantification","pmids":["30309881"],"confidence":"High","gaps":["Structural basis of RBM47 vs. A1CF preference for different editing sites unknown","Mechanistic basis of tissue-specific cofactor utilization not defined"]},{"year":2020,"claim":"The crystal structure of APOBEC1 revealed a unique C-terminal hydrophobic domain (A1HD) that mediates stable dimerization and forms a positively charged β-sheet surface that directs RNA versus DNA substrate selectivity and cofactor interactions, finally providing structural explanations for dimerization and dual substrate activity.","evidence":"X-ray crystallography with structure-guided mutagenesis and substrate selectivity assays","pmids":["33094286"],"confidence":"High","gaps":["No structure of APOBEC1 in complex with ACF/RBM47 or RNA substrate","Conformational dynamics during catalysis not captured"]},{"year":2021,"claim":"RPA was shown to suppress APOBEC1 DNA deamination activity by outcompeting it for ssDNA binding, providing a mechanistic explanation for why APOBEC1 expression causes limited genomic damage despite its intrinsic DNA mutator activity.","evidence":"In vitro deamination assays with RPA competition; γH2AX foci measurement in lung cancer cells","pmids":["33330905"],"confidence":"Medium","gaps":["In vivo validation of RPA protection against APOBEC1-mediated mutagenesis lacking","Whether replication stress or RPA depletion unmasks APOBEC1 DNA damage in physiological settings is untested"]},{"year":null,"claim":"A high-resolution structure of the complete APOBEC1–RBM47(or A1CF)–RNA ternary complex is needed to understand how cofactor binding remodels the RNA substrate and positions the target cytidine in the active site, and the physiological significance of APOBEC1-mediated DNA deamination in normal somatic tissues remains unresolved.","evidence":"","pmids":[],"confidence":"Low","gaps":["No ternary complex structure available","In vivo contribution of APOBEC1 to somatic mutagenesis in healthy tissues unknown","Full functional consequences of 3′ UTR editing on mRNA fate and translation not systematically characterized"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140098","term_label":"catalytic activity, acting on RNA","supporting_discovery_ids":[0,2,3,8,22,27,31]},{"term_id":"GO:0140097","term_label":"catalytic activity, acting on DNA","supporting_discovery_ids":[15,17,30]},{"term_id":"GO:0003723","term_label":"RNA binding","supporting_discovery_ids":[1,7,20,26]},{"term_id":"GO:0016787","term_label":"hydrolase activity","supporting_discovery_ids":[0,17]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[10,14,25]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[10,25]}],"pathway":[{"term_id":"R-HSA-8953854","term_label":"Metabolism of RNA","supporting_discovery_ids":[2,8,22,27,31,34]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[26]}],"complexes":["apoB mRNA editosome"],"partners":["A1CF","RBM47","CUGBP2","GRY-RBP","ABBP-1","DNAJB1","SYNCRIP"],"other_free_text":[]},"mechanistic_narrative":"APOBEC1 is a zinc-dependent cytidine deaminase that serves as the catalytic subunit of the apolipoprotein B mRNA editing holoenzyme, converting C6666 to U to produce apoB48, and edits dozens of additional mRNA targets predominantly in 3′ UTRs [PMID:8626621, PMID:21258325, PMID:24946870]. APOBEC1 requires RNA-binding cofactors—RBM47 as the principal in vivo partner and A1CF contributing in a tissue-specific manner—that recognize the mooring sequence and remodel the RNA stem-loop to expose the target cytidine for deamination [PMID:10669759, PMID:24916387, PMID:30309881, PMID:15659357]. Beyond RNA editing, APOBEC1 binds AU-rich elements in 3′ UTRs of mRNAs such as COX-2, c-myc, Cyp7a1, and IL-8, stabilizing them post-transcriptionally through a mechanism dependent on its RNA-binding activity but independent of catalytic editing [PMID:10688645, PMID:15480992, PMID:19386592, PMID:25100733]. APOBEC1 also deaminates cytosines in single-stranded DNA in a sequence-context-dependent manner that is suppressed by RPA binding, and its homodimeric structure—mediated by a unique C-terminal hydrophobic domain—governs substrate selectivity between RNA and DNA [PMID:12697753, PMID:33094286, PMID:33330905]."},"prefetch_data":{"uniprot":{"accession":"P41238","full_name":"C->U-editing enzyme APOBEC-1","aliases":["Apolipoprotein B mRNA-editing enzyme catalytic subunit 1","APO1","APOBEC-1","Apolipoprotein B mRNA-editing enzyme 1","HEPR","mRNA(cytosine(6666)) deaminase 1"],"length_aa":236,"mass_kda":28.2,"function":"Cytidine deaminase catalyzing the cytidine to uridine postranscriptional editing of a variety of mRNAs (PubMed:30844405). Form complexes with cofactors that confer differential editing activity and selectivity. Responsible for the postranscriptional editing of a CAA codon for Gln to a UAA codon for stop in the apolipoprotein B mRNA (PubMed:24916387). Also involved in CGA (Arg) to UGA (Stop) editing in the NF1 mRNA (PubMed:11727199). May also play a role in the epigenetic regulation of gene expression by participating in DNA demethylation (By similarity)","subcellular_location":"Cytoplasm; Nucleus","url":"https://www.uniprot.org/uniprotkb/P41238/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/APOBEC1","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/APOBEC1","total_profiled":1310},"omim":[{"mim_id":"618199","title":"APOBEC1 COMPLEMENTATION FACTOR; A1CF","url":"https://www.omim.org/entry/618199"},{"mim_id":"616686","title":"SYNAPTOTAGMIN-BINDING CYTOPLASMIC RNA-INTERACTING PROTEIN; SYNCRIP","url":"https://www.omim.org/entry/616686"},{"mim_id":"613113","title":"NEUROFIBROMIN 1; NF1","url":"https://www.omim.org/entry/613113"},{"mim_id":"611341","title":"DNAJ/HSP40 HOMOLOG, SUBFAMILY B, MEMBER 11; DNAJB11","url":"https://www.omim.org/entry/611341"},{"mim_id":"609908","title":"APOLIPOPROTEIN B mRNA-EDITING ENZYME, CATALYTIC POLYPEPTIDE-LIKE 4; APOBEC4","url":"https://www.omim.org/entry/609908"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"intestine","ntpm":27.3}],"url":"https://www.proteinatlas.org/search/APOBEC1"},"hgnc":{"alias_symbol":["BEDP","CDAR1","APOBEC-1","HEPR"],"prev_symbol":[]},"alphafold":{"accession":"P41238","domains":[{"cath_id":"3.40.140.10","chopping":"9-171","consensus_level":"medium","plddt":90.452,"start":9,"end":171},{"cath_id":"-","chopping":"172-236","consensus_level":"medium","plddt":86.8631,"start":172,"end":236}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P41238","model_url":"https://alphafold.ebi.ac.uk/files/AF-P41238-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P41238-F1-predicted_aligned_error_v6.png","plddt_mean":87.94},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=APOBEC1","jax_strain_url":"https://www.jax.org/strain/search?query=APOBEC1"},"sequence":{"accession":"P41238","fasta_url":"https://rest.uniprot.org/uniprotkb/P41238.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P41238/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P41238"}},"corpus_meta":[{"pmid":"12453430","id":"PMC_12453430","title":"RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators.","date":"2002","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/12453430","citation_count":478,"is_preprint":false},{"pmid":"10669759","id":"PMC_10669759","title":"Molecular cloning of apobec-1 complementation factor, a novel RNA-binding protein involved in the editing of apolipoprotein B mRNA.","date":"2000","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/10669759","citation_count":215,"is_preprint":false},{"pmid":"21258325","id":"PMC_21258325","title":"Transcriptome-wide sequencing reveals numerous APOBEC1 mRNA-editing targets in transcript 3' UTRs.","date":"2011","source":"Nature structural & molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/21258325","citation_count":194,"is_preprint":false},{"pmid":"18068040","id":"PMC_18068040","title":"Recombinant antibodies to an oxidized low-density lipoprotein epitope induce rapid regression of atherosclerosis in apobec-1(-/-)/low-density lipoprotein receptor(-/-) mice.","date":"2007","source":"Journal of the American College of Cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/18068040","citation_count":137,"is_preprint":false},{"pmid":"8626621","id":"PMC_8626621","title":"Targeted disruption of the mouse apobec-1 gene abolishes apolipoprotein B mRNA editing and eliminates apolipoprotein B48.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8626621","citation_count":129,"is_preprint":false},{"pmid":"12697753","id":"PMC_12697753","title":"In vitro deamination of cytosine to uracil in single-stranded DNA by apolipoprotein B editing complex catalytic subunit 1 (APOBEC1).","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12697753","citation_count":114,"is_preprint":false},{"pmid":"7782343","id":"PMC_7782343","title":"Mutagenesis of apobec-1, the catalytic subunit of the mammalian apolipoprotein B mRNA editing enzyme, reveals distinct domains that mediate cytosine nucleoside deaminase, RNA binding, and RNA editing activity.","date":"1995","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7782343","citation_count":112,"is_preprint":false},{"pmid":"7782342","id":"PMC_7782342","title":"apobec-1, the catalytic subunit of the mammalian apolipoprotein B mRNA editing enzyme, is a novel RNA-binding protein.","date":"1995","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7782342","citation_count":108,"is_preprint":false},{"pmid":"20836050","id":"PMC_20836050","title":"APOBEC-1-mediated RNA editing.","date":"2010","source":"Wiley interdisciplinary reviews. Systems biology and medicine","url":"https://pubmed.ncbi.nlm.nih.gov/20836050","citation_count":102,"is_preprint":false},{"pmid":"24916387","id":"PMC_24916387","title":"C to U RNA editing mediated by APOBEC1 requires RNA-binding protein RBM47.","date":"2014","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/24916387","citation_count":94,"is_preprint":false},{"pmid":"7768898","id":"PMC_7768898","title":"Alternative mRNA splicing and differential promoter utilization determine tissue-specific expression of the apolipoprotein B mRNA-editing protein (Apobec1) gene in mice. Structure and evolution of Apobec1 and related nucleoside/nucleotide deaminases.","date":"1995","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7768898","citation_count":93,"is_preprint":false},{"pmid":"25085003","id":"PMC_25085003","title":"The RNA editing enzyme APOBEC1 induces somatic mutations and a compatible mutational signature is present in esophageal adenocarcinomas.","date":"2014","source":"Genome biology","url":"https://pubmed.ncbi.nlm.nih.gov/25085003","citation_count":85,"is_preprint":false},{"pmid":"11134005","id":"PMC_11134005","title":"Identification of GRY-RBP as an apolipoprotein B RNA-binding protein that interacts with both apobec-1 and apobec-1 complementation factor to modulate C to U editing.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11134005","citation_count":85,"is_preprint":false},{"pmid":"11577082","id":"PMC_11577082","title":"Novel role for RNA-binding protein CUGBP2 in mammalian RNA editing. CUGBP2 modulates C to U editing of apolipoprotein B mRNA by interacting with apobec-1 and ACF, the apobec-1 complementation factor.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11577082","citation_count":84,"is_preprint":false},{"pmid":"8621694","id":"PMC_8621694","title":"Overexpression of APOBEC-1 results in mooring sequence-dependent promiscuous RNA editing.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8621694","citation_count":83,"is_preprint":false},{"pmid":"8824235","id":"PMC_8824235","title":"Complete phenotypic characterization of apobec-1 knockout mice with a wild-type genetic background and a human apolipoprotein B transgenic background, and restoration of apolipoprotein B mRNA editing by somatic gene transfer of Apobec-1.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8824235","citation_count":83,"is_preprint":false},{"pmid":"8999813","id":"PMC_8999813","title":"Cloning of an Apobec-1-binding protein that also interacts with apolipoprotein B mRNA and evidence for its involvement in RNA editing.","date":"1997","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8999813","citation_count":83,"is_preprint":false},{"pmid":"24946870","id":"PMC_24946870","title":"Genome-wide identification and functional analysis of Apobec-1-mediated C-to-U RNA editing in mouse small intestine and liver.","date":"2014","source":"Genome biology","url":"https://pubmed.ncbi.nlm.nih.gov/24946870","citation_count":82,"is_preprint":false},{"pmid":"10688645","id":"PMC_10688645","title":"An AU-rich sequence element (UUUN[A/U]U) downstream of the edited C in apolipoprotein B mRNA is a high-affinity binding site for Apobec-1: binding of Apobec-1 to this motif in the 3' untranslated region of c-myc increases mRNA stability.","date":"2000","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/10688645","citation_count":74,"is_preprint":false},{"pmid":"15148397","id":"PMC_15148397","title":"The structure of a yeast RNA-editing deaminase provides insight into the fold and function of activation-induced deaminase and APOBEC-1.","date":"2004","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/15148397","citation_count":74,"is_preprint":false},{"pmid":"18983852","id":"PMC_18983852","title":"Murine APOBEC1 is a powerful mutator of retroviral and cellular RNA in vitro and in vivo.","date":"2008","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/18983852","citation_count":63,"is_preprint":false},{"pmid":"9084497","id":"PMC_9084497","title":"Apobec-1 and apolipoprotein B mRNA editing.","date":"1997","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/9084497","citation_count":58,"is_preprint":false},{"pmid":"11871661","id":"PMC_11871661","title":"Identification of domains in apobec-1 complementation factor required for RNA binding and apolipoprotein-B mRNA editing.","date":"2002","source":"RNA (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/11871661","citation_count":56,"is_preprint":false},{"pmid":"8626710","id":"PMC_8626710","title":"Hyperediting of multiple cytidines of apolipoprotein B mRNA by APOBEC-1 requires auxiliary protein(s) but not a mooring sequence motif.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8626710","citation_count":55,"is_preprint":false},{"pmid":"10469298","id":"PMC_10469298","title":"Psoriasis upregulated phorbolin-1 shares structural but not functional similarity to the mRNA-editing protein apobec-1.","date":"1999","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/10469298","citation_count":53,"is_preprint":false},{"pmid":"21398638","id":"PMC_21398638","title":"Intrinsic restriction activity by apolipoprotein B mRNA editing enzyme APOBEC1 against the mobility of autonomous retrotransposons.","date":"2011","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/21398638","citation_count":52,"is_preprint":false},{"pmid":"11727199","id":"PMC_11727199","title":"C-->U editing of neurofibromatosis 1 mRNA occurs in tumors that express both the type II transcript and apobec-1, the catalytic subunit of the apolipoprotein B mRNA-editing enzyme.","date":"2001","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11727199","citation_count":52,"is_preprint":false},{"pmid":"8910449","id":"PMC_8910449","title":"Apobec-1 interacts with a 65-kDa complementing protein to edit apolipoprotein-B mRNA in vitro.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8910449","citation_count":51,"is_preprint":false},{"pmid":"8727508","id":"PMC_8727508","title":"Hepatic expression of the catalytic subunit of the apolipoprotein B mRNA editing enzyme (apobec-1) ameliorates hypercholesterolemia in LDL receptor-deficient rabbits.","date":"1996","source":"Human gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/8727508","citation_count":50,"is_preprint":false},{"pmid":"33445170","id":"PMC_33445170","title":"Apobec1 complementation factor overexpression promotes hepatic steatosis, fibrosis, and hepatocellular cancer.","date":"2021","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/33445170","citation_count":48,"is_preprint":false},{"pmid":"22923694","id":"PMC_22923694","title":"Transgenerational epigenetic effects of the Apobec1 cytidine deaminase deficiency on testicular germ cell tumor susceptibility and embryonic viability.","date":"2012","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/22923694","citation_count":48,"is_preprint":false},{"pmid":"11698249","id":"PMC_11698249","title":"ARCD-1, an apobec-1-related cytidine deaminase, exerts a dominant negative effect on C to U RNA editing.","date":"2001","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/11698249","citation_count":48,"is_preprint":false},{"pmid":"9671452","id":"PMC_9671452","title":"A sequence-specific RNA-binding protein complements apobec-1 To edit apolipoprotein B mRNA.","date":"1998","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/9671452","citation_count":47,"is_preprint":false},{"pmid":"16055734","id":"PMC_16055734","title":"Targeted deletion of the murine apobec-1 complementation factor (acf) gene results in embryonic lethality.","date":"2005","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/16055734","citation_count":45,"is_preprint":false},{"pmid":"10833526","id":"PMC_10833526","title":"Induction of cytidine to uridine editing on cytoplasmic apolipoprotein B mRNA by overexpressing APOBEC-1.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10833526","citation_count":45,"is_preprint":false},{"pmid":"11571303","id":"PMC_11571303","title":"Mutagenesis of apobec-1 complementation factor reveals distinct domains that modulate RNA binding, protein-protein interaction with apobec-1, and complementation of C to U RNA-editing activity.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11571303","citation_count":44,"is_preprint":false},{"pmid":"15659357","id":"PMC_15659357","title":"NMR structure of the apoB mRNA stem-loop and its interaction with the C to U editing APOBEC1 complementary factor.","date":"2005","source":"RNA (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/15659357","citation_count":42,"is_preprint":false},{"pmid":"12896982","id":"PMC_12896982","title":"A novel nuclear localization signal in the auxiliary domain of apobec-1 complementation factor regulates nucleocytoplasmic import and shuttling.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12896982","citation_count":42,"is_preprint":false},{"pmid":"25344410","id":"PMC_25344410","title":"High-resolution genetic mapping in the diversity outbred mouse population identifies Apobec1 as a candidate gene for atherosclerosis.","date":"2014","source":"G3 (Bethesda, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/25344410","citation_count":41,"is_preprint":false},{"pmid":"30309881","id":"PMC_30309881","title":"Apobec1 complementation factor (A1CF) and RBM47 interact in tissue-specific regulation of C to U RNA editing in mouse intestine and liver.","date":"2018","source":"RNA (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/30309881","citation_count":41,"is_preprint":false},{"pmid":"21172829","id":"PMC_21172829","title":"Analysis of reptilian APOBEC1 suggests that RNA editing may not be its ancestral function.","date":"2010","source":"Molecular biology and evolution","url":"https://pubmed.ncbi.nlm.nih.gov/21172829","citation_count":40,"is_preprint":false},{"pmid":"11584023","id":"PMC_11584023","title":"A DnaJ protein, apobec-1-binding protein-2, modulates apolipoprotein B mRNA editing.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11584023","citation_count":39,"is_preprint":false},{"pmid":"29167375","id":"PMC_29167375","title":"Loss of APOBEC1 RNA-editing function in microglia exacerbates age-related CNS pathophysiology.","date":"2017","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/29167375","citation_count":38,"is_preprint":false},{"pmid":"18971252","id":"PMC_18971252","title":"The antiretroviral potency of APOBEC1 deaminase from small animal species.","date":"2008","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/18971252","citation_count":37,"is_preprint":false},{"pmid":"9346911","id":"PMC_9346911","title":"Partial characterization of the auxiliary factors involved in apolipoprotein B mRNA editing through APOBEC-1 affinity chromatography.","date":"1997","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9346911","citation_count":37,"is_preprint":false},{"pmid":"20546753","id":"PMC_20546753","title":"APOBEC1 and APOBEC3 cytidine deaminases as restriction factors for hepadnaviral genomes in non-humans in vivo.","date":"2010","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/20546753","citation_count":37,"is_preprint":false},{"pmid":"8999814","id":"PMC_8999814","title":"Tissue-specific inhibition of apolipoprotein B mRNA editing in the liver by adenovirus-mediated transfer of a dominant negative mutant APOBEC-1 leads to increased low density lipoprotein in mice.","date":"1997","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8999814","citation_count":36,"is_preprint":false},{"pmid":"8825867","id":"PMC_8825867","title":"Gene transfer of cytidine deaminase apoBEC-1 lowers lipoprotein(a) in transgenic mice and induces apolipoprotein B editing in rabbits.","date":"1996","source":"Human gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/8825867","citation_count":36,"is_preprint":false},{"pmid":"16798720","id":"PMC_16798720","title":"PI3-kinase activity modulates apo B available for hepatic VLDL production in apobec-1-/- mice.","date":"2006","source":"American journal of physiology. Gastrointestinal and liver physiology","url":"https://pubmed.ncbi.nlm.nih.gov/16798720","citation_count":35,"is_preprint":false},{"pmid":"21775448","id":"PMC_21775448","title":"APOBEC1-mediated editing and attenuation of herpes simplex virus 1 DNA indicate that neurons have an antiviral role during herpes simplex encephalitis.","date":"2011","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/21775448","citation_count":35,"is_preprint":false},{"pmid":"11352648","id":"PMC_11352648","title":"Two-hybrid cloning identifies an RNA-binding protein, GRY-RBP, as a component of apobec-1 editosome.","date":"2001","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/11352648","citation_count":35,"is_preprint":false},{"pmid":"12816761","id":"PMC_12816761","title":"Intestinal lipoprotein assembly in apobec-1-/- mice reveals subtle alterations in triglyceride secretion coupled with a shift to larger lipoproteins.","date":"2003","source":"American journal of physiology. Gastrointestinal and liver physiology","url":"https://pubmed.ncbi.nlm.nih.gov/12816761","citation_count":33,"is_preprint":false},{"pmid":"10191286","id":"PMC_10191286","title":"Mutational analysis of apolipoprotein B mRNA editing enzyme (APOBEC1). structure-function relationships of RNA editing and dimerization.","date":"1999","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/10191286","citation_count":33,"is_preprint":false},{"pmid":"11718896","id":"PMC_11718896","title":"Isolation, characterization and developmental regulation of the human apobec-1 complementation factor (ACF) gene.","date":"2001","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/11718896","citation_count":32,"is_preprint":false},{"pmid":"15480992","id":"PMC_15480992","title":"Apobec-1 protects intestine from radiation injury through posttranscriptional regulation of cyclooxygenase-2 expression.","date":"2004","source":"Gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/15480992","citation_count":31,"is_preprint":false},{"pmid":"7595088","id":"PMC_7595088","title":"Developmental regulation of the catalytic subunit of the apolipoprotein B mRNA editing enzyme (APOBEC-1) in human small intestine.","date":"1995","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/7595088","citation_count":31,"is_preprint":false},{"pmid":"28069890","id":"PMC_28069890","title":"APOBEC1 complementation factor (A1CF) is dispensable for C-to-U RNA editing in vivo.","date":"2017","source":"RNA (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/28069890","citation_count":29,"is_preprint":false},{"pmid":"20890106","id":"PMC_20890106","title":"apoB and apobec1, two genes key to lipid metabolism, are transcriptionally regulated by p53.","date":"2010","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/20890106","citation_count":29,"is_preprint":false},{"pmid":"9797364","id":"PMC_9797364","title":"An alternatively spliced form of apobec-1 messenger RNA is overexpressed in human colon cancer.","date":"1998","source":"Gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/9797364","citation_count":29,"is_preprint":false},{"pmid":"19843348","id":"PMC_19843348","title":"Human APOBEC1 cytidine deaminase edits HBV DNA.","date":"2009","source":"Retrovirology","url":"https://pubmed.ncbi.nlm.nih.gov/19843348","citation_count":28,"is_preprint":false},{"pmid":"15273326","id":"PMC_15273326","title":"Optimization of apolipoprotein B mRNA editing by APOBEC1 apoenzyme and the role of its auxiliary factor, ACF.","date":"2004","source":"RNA (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/15273326","citation_count":28,"is_preprint":false},{"pmid":"17875695","id":"PMC_17875695","title":"Deletion of the AU-rich RNA binding protein Apobec-1 reduces intestinal tumor burden in Apc(min) mice.","date":"2007","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/17875695","citation_count":28,"is_preprint":false},{"pmid":"14559972","id":"PMC_14559972","title":"RNA-editing cytidine deaminase Apobec-1 is unable to induce somatic hypermutation in mammalian cells.","date":"2003","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/14559972","citation_count":27,"is_preprint":false},{"pmid":"16999936","id":"PMC_16999936","title":"APOBEC-1 and AID are nucleo-cytoplasmic trafficking proteins but APOBEC3G cannot traffic.","date":"2006","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/16999936","citation_count":27,"is_preprint":false},{"pmid":"9157952","id":"PMC_9157952","title":"Effective lowering of plasma, LDL, and esterified cholesterol in LDL receptor-knockout mice by adenovirus-mediated gene delivery of ApoB mRNA editing enzyme (Apobec1).","date":"1997","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/9157952","citation_count":27,"is_preprint":false},{"pmid":"31337756","id":"PMC_31337756","title":"Mitochondrially-targeted APOBEC1 is a potent mtDNA mutator affecting mitochondrial function and organismal fitness in Drosophila.","date":"2019","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/31337756","citation_count":26,"is_preprint":false},{"pmid":"33330905","id":"PMC_33330905","title":"APOBEC1 cytosine deaminase activity on single-stranded DNA is suppressed by replication protein A.","date":"2021","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/33330905","citation_count":25,"is_preprint":false},{"pmid":"9186903","id":"PMC_9186903","title":"Characterization of the human apobec-1 gene: expression in gastrointestinal tissues determined by alternative splicing with production of a novel truncated peptide.","date":"1997","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/9186903","citation_count":25,"is_preprint":false},{"pmid":"20406809","id":"PMC_20406809","title":"Apobec-1 complementation factor modulates liver regeneration by post-transcriptional regulation of interleukin-6 mRNA stability.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20406809","citation_count":25,"is_preprint":false},{"pmid":"33094286","id":"PMC_33094286","title":"The structure of APOBEC1 and insights into its RNA and DNA substrate selectivity.","date":"2020","source":"NAR cancer","url":"https://pubmed.ncbi.nlm.nih.gov/33094286","citation_count":24,"is_preprint":false},{"pmid":"17855359","id":"PMC_17855359","title":"Conditional intestinal lipotoxicity in Apobec-1-/- Mttp-IKO mice: a survival advantage for mammalian intestinal apolipoprotein B mRNA editing.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17855359","citation_count":23,"is_preprint":false},{"pmid":"30844405","id":"PMC_30844405","title":"Comparison of RNA Editing Activity of APOBEC1-A1CF and APOBEC1-RBM47 Complexes Reconstituted in HEK293T Cells.","date":"2019","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/30844405","citation_count":22,"is_preprint":false},{"pmid":"16820530","id":"PMC_16820530","title":"Metabolic regulation of apoB mRNA editing is associated with phosphorylation of APOBEC-1 complementation factor.","date":"2006","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/16820530","citation_count":22,"is_preprint":false},{"pmid":"9479499","id":"PMC_9479499","title":"Human apolipoprotein B RNA editing deaminase gene (APOBEC1).","date":"1998","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/9479499","citation_count":20,"is_preprint":false},{"pmid":"19386592","id":"PMC_19386592","title":"Decreased expression of cholesterol 7alpha-hydroxylase and altered bile acid metabolism in Apobec-1-/- mice lead to increased gallstone susceptibility.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19386592","citation_count":20,"is_preprint":false},{"pmid":"10597235","id":"PMC_10597235","title":"Absence of APOBEC-1 mediated mRNA editing in human carcinomas.","date":"1999","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/10597235","citation_count":19,"is_preprint":false},{"pmid":"9667237","id":"PMC_9667237","title":"Insulin increases expression of apobec-1, the catalytic subunit of the apolipoprotein B mRNA editing complex in rat hepatocytes.","date":"1998","source":"Metabolism: clinical and experimental","url":"https://pubmed.ncbi.nlm.nih.gov/9667237","citation_count":19,"is_preprint":false},{"pmid":"14570923","id":"PMC_14570923","title":"Identification of novel alternative splice variants of APOBEC-1 complementation factor with different capacities to support apolipoprotein B mRNA editing.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14570923","citation_count":19,"is_preprint":false},{"pmid":"9672068","id":"PMC_9672068","title":"Distinct promoters induce APOBEC-1 expression in rat liver and intestine.","date":"1998","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/9672068","citation_count":19,"is_preprint":false},{"pmid":"33057101","id":"PMC_33057101","title":"RNA editing of BFP, a point mutant of GFP, using artificial APOBEC1 deaminase to restore the genetic code.","date":"2020","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/33057101","citation_count":18,"is_preprint":false},{"pmid":"20348446","id":"PMC_20348446","title":"Hypermutation induced by APOBEC-1 overexpression can be eliminated.","date":"2010","source":"RNA (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/20348446","citation_count":18,"is_preprint":false},{"pmid":"10502408","id":"PMC_10502408","title":"Disproportionate relationship between APOBEC-1 expression and apolipoprotein B mRNA editing activity.","date":"1999","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/10502408","citation_count":17,"is_preprint":false},{"pmid":"9215539","id":"PMC_9215539","title":"Cloning and characterization of the rat apobec-1 gene: a comparative analysis of gene structure and promoter usage in rat and mouse.","date":"1997","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/9215539","citation_count":17,"is_preprint":false},{"pmid":"25303118","id":"PMC_25303118","title":"Reassessment of murine APOBEC1 as a retrovirus restriction factor in vivo.","date":"2014","source":"Virology","url":"https://pubmed.ncbi.nlm.nih.gov/25303118","citation_count":16,"is_preprint":false},{"pmid":"15145984","id":"PMC_15145984","title":"Hepatic secretion of small lipoprotein particles in apobec-1-/- mice is regulated by the LDL receptor.","date":"2004","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/15145984","citation_count":16,"is_preprint":false},{"pmid":"10373583","id":"PMC_10373583","title":"C-->U editing of apolipoprotein B mRNA in marsupials: identification and characterisation of APOBEC-1 from the American opossum Monodelphus domestica.","date":"1999","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/10373583","citation_count":16,"is_preprint":false},{"pmid":"22993231","id":"PMC_22993231","title":"Intestine-specific expression of Apobec-1 rescues apolipoprotein B RNA editing and alters chylomicron production in Apobec1 -/- mice.","date":"2012","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/22993231","citation_count":16,"is_preprint":false},{"pmid":"8579594","id":"PMC_8579594","title":"In vitro reconstitution of apolipoprotein B RNA editing activity from recombinant APOBEC-1 and McArdle cell extracts.","date":"1996","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/8579594","citation_count":16,"is_preprint":false},{"pmid":"12374571","id":"PMC_12374571","title":"Regulatable liver expression of the rabbit apolipoprotein B mRNA-editing enzyme catalytic polypeptide 1 (APOBEC-1) in mice lacking endogenous APOBEC-1 leads to aberrant hyperediting.","date":"2003","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/12374571","citation_count":15,"is_preprint":false},{"pmid":"17010310","id":"PMC_17010310","title":"The acidic domain of hnRNPQ (NSAP1) has structural similarity to Barstar and binds to Apobec1.","date":"2006","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/17010310","citation_count":13,"is_preprint":false},{"pmid":"12020819","id":"PMC_12020819","title":"Apobec-1 transcription in rat colon cancer: decreased apobec-1 protein production through alterations in polysome distribution and mRNA translation associated with upstream AUGs.","date":"2002","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/12020819","citation_count":13,"is_preprint":false},{"pmid":"9792440","id":"PMC_9792440","title":"Evolutionary origins of the mammalian apolipoproteinB RNA editing enzyme, apobec-1: structural homology inferred from analysis of a cloned chicken small intestinal cytidine deaminase.","date":"1998","source":"Biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9792440","citation_count":13,"is_preprint":false},{"pmid":"25100733","id":"PMC_25100733","title":"The RNA-editing enzyme APOBEC1 requires heterogeneous nuclear ribonucleoprotein Q isoform 6 for efficient interaction with interleukin-8 mRNA.","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25100733","citation_count":12,"is_preprint":false},{"pmid":"10606639","id":"PMC_10606639","title":"APOBEC-1 dependent cytidine to uridine editing of apolipoprotein B RNA in yeast.","date":"2000","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/10606639","citation_count":12,"is_preprint":false},{"pmid":"26848653","id":"PMC_26848653","title":"Apobec-1 Complementation Factor (A1CF) Inhibits Epithelial-Mesenchymal Transition and Migration of Normal Rat Kidney Proximal Tubular Epithelial Cells.","date":"2016","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/26848653","citation_count":12,"is_preprint":false},{"pmid":"24249727","id":"PMC_24249727","title":"The genetic basis for individual differences in mRNA splicing and APOBEC1 editing activity in murine macrophages.","date":"2013","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/24249727","citation_count":12,"is_preprint":false},{"pmid":"28429755","id":"PMC_28429755","title":"Opossum APOBEC1 is a DNA mutator with retrovirus and retroelement restriction activity.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28429755","citation_count":11,"is_preprint":false},{"pmid":"20541536","id":"PMC_20541536","title":"APOBEC-1 complementation factor (ACF) forms RNA-dependent multimers.","date":"2010","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/20541536","citation_count":11,"is_preprint":false},{"pmid":"17229474","id":"PMC_17229474","title":"Functional characterization of APOBEC-1 complementation factor phosphorylation sites.","date":"2006","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/17229474","citation_count":11,"is_preprint":false},{"pmid":"20541607","id":"PMC_20541607","title":"Metabolic regulation of APOBEC-1 complementation factor trafficking in mouse models of obesity and its positive correlation with the expression of ApoB protein in hepatocytes.","date":"2010","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/20541607","citation_count":11,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":49797,"output_tokens":8668,"usd":0.139706},"stage2":{"model":"claude-opus-4-6","input_tokens":12536,"output_tokens":3910,"usd":0.240645},"total_usd":0.380351,"stage1_batch_id":"msgbatch_01TqNM6p6FsoMBT2jzQTwKBr","stage2_batch_id":"msgbatch_01Ya473eco8sTHbvRymQaU8o","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1995,\n      \"finding\": \"APOBEC1 contains distinct functional domains: a zinc-coordinating catalytic domain (H61, E63, C93, C96) required for cytidine deaminase activity and apoB RNA editing, a leucine-rich region (LRR) required for RNA editing but not deaminase activity, and an RNA-binding domain; mutation of H61→Arg abolishes RNA binding while E63→Gln and C96→Ser mutants retain RNA binding but lose editing activity. Overexpression acts as a dominant negative when RNA binding is eliminated.\",\n      \"method\": \"Site-directed mutagenesis of GST-APOBEC1 fusion protein, in vitro cytidine deaminase assays, UV cross-linking RNA binding assays, transient transfection in McA 7777 cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution with mutagenesis of multiple catalytic residues, orthogonal functional assays\",\n      \"pmids\": [\"7782343\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"Recombinant APOBEC1 binds with high specificity to apoB RNA in AU-rich sequences, demonstrated by UV cross-linking and EMSA; binding is competed by poly(U) and poly(A,U) but not poly(A); binding specificity for the RNA template is distinct from editing specificity.\",\n      \"method\": \"UV cross-linking, electrophoretic mobility shift assay (EMSA), RNA competition assays with recombinant GST-APOBEC1\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with multiple orthogonal methods\",\n      \"pmids\": [\"7782342\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Targeted disruption of mouse apobec-1 abolishes all apoB mRNA editing and eliminates apoB48 production in all tissues, demonstrating APOBEC1 is the essential catalytic subunit with no functional gene duplication.\",\n      \"method\": \"Gene targeting/knockout mice, apoB mRNA editing assay, Western blot for apoB48\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean knockout with defined molecular phenotype, replicated by second independent KO study\",\n      \"pmids\": [\"8626621\", \"8824235\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Overexpression of APOBEC1 in stable rat hepatoma cell lines results in promiscuous RNA editing of cytidines 5' of the mooring sequence in addition to the wild-type site, and this promiscuous editing is mooring sequence-dependent and increases with APOBEC1 expression level.\",\n      \"method\": \"Stable cell lines overexpressing APOBEC1, apoB RNA editing assays, sequence analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — cell-based overexpression with clear dose-response and defined molecular readout\",\n      \"pmids\": [\"8621694\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"APOBEC1 requires a 65-kDa complementing protein (later identified as ACF) for apoB mRNA editing activity in vitro; this protein interacts directly with APOBEC1 in the absence of apoB mRNA, as demonstrated by APOBEC1 affinity chromatography.\",\n      \"method\": \"Affinity chromatography using immobilized recombinant His6-APOBEC1, size exclusion chromatography, glycerol gradient sedimentation, functional in vitro editing assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — biochemical reconstitution with purified components, direct pulldown\",\n      \"pmids\": [\"8910449\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"APOBEC1 functions as a homodimer; a catalytically inactive mutant (H61K/C93S/C96S) that retains dimerization capacity acts as a dominant negative inhibitor of wild-type APOBEC1 editing activity in vivo, while mutants that dimerize poorly do not inhibit.\",\n      \"method\": \"In vitro editing assay, co-immunoprecipitation of epitope-tagged APOBEC1 mutants, adenoviral delivery to mice\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal co-IP plus in vitro assay plus in vivo validation\",\n      \"pmids\": [\"8999814\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"ABBP-1, an hnRNP-type RNA-binding protein, interacts with APOBEC1 via its glycine-rich C-terminal domain and binds apoB mRNA; immunodepletion of ABBP-1 from editing extracts inhibits editing activity.\",\n      \"method\": \"Yeast two-hybrid screening, deletion mapping, UV cross-linking, immunodepletion, antisense knockdown in HepG2 cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — yeast two-hybrid plus immunodepletion, single lab\",\n      \"pmids\": [\"8999813\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"APOBEC1 exhibits a consensus high-affinity binding site for AU-rich RNA of sequence UUUN[A/U]U; binding to the c-myc 3'UTR containing this motif stabilizes c-myc mRNA (half-life increased from 90 to 240 min), an effect dependent on APOBEC1 RNA-binding activity.\",\n      \"method\": \"Filter binding assays, circular-permutation analysis, actinomycin D mRNA turnover assays in transfected F442A cells with RNA-binding mutants\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — binding site defined biochemically, functional mRNA stabilization confirmed with RNA-binding mutant controls\",\n      \"pmids\": [\"10688645\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"ACF (apobec-1 complementation factor), a 65-kDa protein with three RNA recognition motifs, is identified as the obligate RNA-binding subunit of the minimal apoB mRNA editing holoenzyme; ACF binds the mooring sequence of apoB mRNA, interacts with APOBEC1, and together they constitute the minimal editing complex.\",\n      \"method\": \"Protein purification, peptide sequencing, molecular cloning, UV cross-linking, co-immunoprecipitation, immunodepletion from liver extracts, in vitro reconstitution of editing\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted minimal holoenzyme in vitro, multiple orthogonal methods, immunodepletion\",\n      \"pmids\": [\"10669759\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"GRY-RBP is an apoB RNA-binding protein that interacts with both APOBEC1 and ACF; it competitively inhibits ACF binding to apoB mRNA and C-to-U editing by sequestering ACF, and antisense knockdown of GRY-RBP increases apoB RNA editing.\",\n      \"method\": \"Two-hybrid screening, recombinant protein pulldowns, RNA binding assays, immunodepletion, antisense oligonucleotide knockdown, confocal colocalization\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods including reconstitution, competition assays, and knockdown\",\n      \"pmids\": [\"11134005\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"APOBEC1-mediated apoB mRNA editing can occur in the cytoplasm when APOBEC1 is overexpressed; under normal conditions editing is restricted to the nucleus. ACF distributes to both nucleus and cytoplasm, providing auxiliary protein support in both compartments.\",\n      \"method\": \"Reporter RNA assays with intron-containing constructs, immunolocalization of ACF and APOBEC1 in McArdle cells, ethanol stimulation experiments\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional editing assay combined with immunolocalization, single lab\",\n      \"pmids\": [\"10833526\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"CUGBP2, a 54-kDa RNA-binding protein, is a component of the apoB mRNA editing holoenzyme; it co-fractionates with ACF, binds apoB RNA upstream of the edited cytidine, and dose-dependently inhibits C-to-U editing in a reconstituted system, rescued by addition of APOBEC1 or ACF.\",\n      \"method\": \"Co-fractionation, co-immunoprecipitation, RNA binding assays, reconstituted editing system, antisense knockdown\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods with reconstitution and knockdown confirmation\",\n      \"pmids\": [\"11577082\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"ARCD-1, an apobec-1 homologue, heterodimerizes with both APOBEC1 and ACF, exhibits cytidine deaminase and apoB RNA binding activity but cannot catalyze C-to-U RNA editing; it acts as a dominant negative inhibitor of APOBEC1-mediated editing.\",\n      \"method\": \"Co-immunoprecipitation, in vitro editing assays, cytidine deaminase assays, subcellular localization by immunofluorescence\",\n      \"journal\": \"American journal of physiology. Cell physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — co-IP plus functional assays, single lab\",\n      \"pmids\": [\"11698249\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"ABBP-2, a DnaJ/Hsp40 family protein, binds APOBEC1 via its J domain and neighboring G/F domain; Hsp70/ABBP-2 interaction (requiring ATP) is necessary for apoB mRNA editing activity in vitro extracts, and ABBP-2 knockdown inhibits endogenous editing.\",\n      \"method\": \"Yeast two-hybrid, co-immunoprecipitation, in vitro editing assays with ATP depletion, ATPase stimulation assays, antisense knockdown\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple binding and functional assays, single lab\",\n      \"pmids\": [\"11584023\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"ACF localizes predominantly to the nucleus; the NH2-terminal 380 residues containing RNA recognition motifs define both apoB RNA binding and APOBEC1-interacting domains. ACF cotransfection with APOBEC1 results in nuclear colocalization and nuclear import of APOBEC1 via protein-protein interaction.\",\n      \"method\": \"Deletion mutagenesis, co-immunoprecipitation, RNA binding assays, confocal microscopy, transfection\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — systematic domain mapping with multiple orthogonal methods and functional validation\",\n      \"pmids\": [\"11571303\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"APOBEC1 and its homologs APOBEC3C and APOBEC3G exhibit potent DNA mutator activity in an E. coli assay through dC deamination, with each protein showing distinct local target sequence specificity.\",\n      \"method\": \"E. coli rifampicin resistance mutation assay, sequence analysis of mutations\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — robust bacterial assay, replicated across multiple family members with sequence specificity characterization\",\n      \"pmids\": [\"12453430\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"ACF requires N-terminal pre-RRM regions and all three RRMs for apoB mRNA binding and complementing activity; the RG-rich auxiliary domain is required for apobec-1 interaction and complementing activity; RRM1 and RRM2 mutations reduce binding affinity by 100-fold while RRM3 reduces it 13-fold.\",\n      \"method\": \"Deletion mutagenesis, point mutagenesis, RNA binding assays measuring Kd, in vitro complementation editing assays\",\n      \"journal\": \"RNA (New York, N.Y.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — systematic mutagenesis with quantitative binding measurements and functional complementation assays\",\n      \"pmids\": [\"11871661\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"APOBEC1 can deaminate cytosine to uracil in single-stranded DNA in vitro, with activity dependent on local sequence context; this establishes APOBEC1 as a dual RNA and DNA cytosine deaminase.\",\n      \"method\": \"In vitro deamination assay using partially purified APOBEC1 from E. coli with ssDNA substrates\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct in vitro biochemical assay demonstrating DNA deamination activity\",\n      \"pmids\": [\"12697753\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"A novel 41-residue motif (ANS) in the auxiliary domain of ACF functions as an authentic nuclear localization signal; ACF nuclear accumulation is transcription-dependent and reversible, and ACF shuttles between nucleus and cytoplasm via binding to the carrier protein transportin 2.\",\n      \"method\": \"GFP/beta-gal chimera localization, actinomycin D treatment, leptomycin B (CRM1 inhibitor), heterokaryon assays, co-immunoprecipitation with transportin 2, confocal microscopy\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal localization methods plus mechanistic identification of nuclear import carrier\",\n      \"pmids\": [\"12896982\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Crystal structure of yeast CDD1 (APOBEC1 ortholog) at 2.0 Å reveals a central active site 'flap' that accommodates large substrates (RNA or DNA) and models of APOBEC1 and AID suggest both are equally likely to bind ssDNA or RNA; the structure explains dimerization and need for trans-acting loops in active site formation.\",\n      \"method\": \"X-ray crystallography at 2.0 Å, comparative structural modeling of APOBEC1 and AID\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure with functional interpretation via comparative modeling\",\n      \"pmids\": [\"15148397\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Apobec-1 binds AU-rich sequences in the 3'UTR of cyclooxygenase-2 (COX-2) mRNA and stabilizes it; deletion of apobec-1 in mice reduces COX-2 mRNA stabilization after irradiation, reducing intestinal stem cell survival through loss of prostaglandin E2-mediated radioprotection.\",\n      \"method\": \"EMSA, UV cross-linking with recombinant APOBEC1, luciferase-COX-2 3'UTR reporter assays, apobec-1 knockout mice with gamma irradiation, clonogenic intestinal crypt survival assay\",\n      \"journal\": \"Gastroenterology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct RNA binding demonstrated biochemically, functional consequence validated with KO mice and defined readout\",\n      \"pmids\": [\"15480992\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"APOBEC1 apoenzyme alone has residual editing activity on minimal apoB mRNA substrate without auxiliary factors; ACF broadens the temperature range of APOBEC1 activity and lowers the optimal temperature, likely by promoting a conformational transition in the RNA substrate.\",\n      \"method\": \"In vitro editing assays with purified recombinant APOBEC1, optimization by incomplete factorial and response surface experiments, steady-state kinetic analysis with and without ACF\",\n      \"journal\": \"RNA (New York, N.Y.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted in vitro system with purified components and kinetic analysis\",\n      \"pmids\": [\"15273326\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"NMR structure of the 31-nt apoB mRNA stem-loop reveals the edited C6666 is stacked in an octa-loop; APOBEC1 alone does not specifically bind apoB mRNA and requires ACF for specific editing; ACF recognizes the flexible mooring sequence and then melts the stem-loop to expose C6666 for deamination.\",\n      \"method\": \"NMR structure determination of apoB mRNA stem-loop, RNA binding assays with APOBEC1 and ACF\",\n      \"journal\": \"RNA (New York, N.Y.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — NMR structure plus functional binding assays defining mechanism of substrate recognition\",\n      \"pmids\": [\"15659357\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"ACF is a metabolically regulated phosphoprotein; serine phosphorylation of ACF (by protein phosphatase I-sensitive kinase) is restricted to nuclear extracts where it co-sediments with editing-competent 27S complexes; ethanol stimulation of editing is associated with 2-3 fold increased ACF phosphorylation; alkaline phosphatase treatment reduces APOBEC1 co-immunoprecipitation with ACF and inhibits editing.\",\n      \"method\": \"Co-immunoprecipitation, alkaline phosphatase treatment, 2D phosphoamino acid analysis, protein phosphatase inhibitors, metabolic stimulation experiments\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal biochemical methods demonstrating phosphorylation regulates editosome assembly\",\n      \"pmids\": [\"16820530\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"PKC phosphorylates ACF at S154 and S368; S154A/S368A mutations inhibit ethanol-stimulated editing while S154D/S368D phosphomimetic mutations stimulate editing to levels comparable to ethanol treatment; PKA has no effect on editing or ACF phosphorylation.\",\n      \"method\": \"In vitro phosphorylation with purified kinases, site-directed mutagenesis, editing assays in primary hepatocytes and McArdle cells\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro kinase assay plus mutagenesis with functional readout\",\n      \"pmids\": [\"17229474\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"APOBEC1 and AID are nucleo-cytoplasmic shuttling proteins, whereas APOBEC3G is strongly retained in the cytoplasm through mechanisms involving both N- and C-terminal regions.\",\n      \"method\": \"Nucleo-cytoplasmic shuttling assays, subcellular fractionation, domain deletion analysis\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct localization experiments with domain mapping, single lab\",\n      \"pmids\": [\"16999936\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"APOBEC1 binds AU-rich sequences in the 3'UTR of Cyp7a1 mRNA (containing UUUN[A/U]U consensus motif) as demonstrated by UV cross-linking and in vivo RNA co-immunoprecipitation, and post-transcriptionally regulates Cyp7a1 expression; apobec-1 deletion decreases Cyp7a1 mRNA without altering transcription, increasing gallstone susceptibility.\",\n      \"method\": \"UV cross-linking with recombinant APOBEC1, in vivo RNA co-immunoprecipitation, apobec-1 knockout mice, adenoviral rescue, hepatocyte nuclear transcription assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct RNA binding demonstrated biochemically plus in vivo validation with KO and rescue\",\n      \"pmids\": [\"19386592\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"APOBEC1 edits 32 previously undescribed mRNA targets located in AU-rich segments of transcript 3'UTRs, as identified by transcriptome-wide comparative RNA sequencing of APOBEC1-expressing versus control cells.\",\n      \"method\": \"Comparative RNA-Seq (transcriptome-wide), Sanger sequencing validation\",\n      \"journal\": \"Nature structural & molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genome-wide approach with Sanger validation, reveals novel substrate class\",\n      \"pmids\": [\"21258325\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"APOBEC1 restricts LINE-1 retrotransposition through a deamination-independent mechanism, and inhibits LTR retrotransposons (IAP, MusD) through a mechanism requiring deaminase activity, as demonstrated in cell culture retrotransposition assays.\",\n      \"method\": \"Cell culture-based retrotransposition assays with wild-type and catalytic mutant APOBEC1, subcellular localization analysis\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional cell-based assays with deaminase-dead mutant controls distinguishing two mechanisms\",\n      \"pmids\": [\"21398638\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"RBM47 is a novel RNA-binding protein that interacts with APOBEC1 and A1CF, can substitute for A1CF in complementing APOBEC1 for C-to-U RNA editing in vitro, and is necessary and sufficient for APOBEC1-mediated editing in vivo as shown by Rbm47-deficient mice with impaired editing.\",\n      \"method\": \"Co-immunoprecipitation, in vitro editing reconstitution, Rbm47 knockout mice, editing assays\",\n      \"journal\": \"EMBO reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vitro reconstitution combined with in vivo KO, multiple labs corroborate\",\n      \"pmids\": [\"24916387\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"APOBEC1 expression induces a mutator phenotype in vertebrate cells through direct targeting of genomic DNA; it increases inactivation of a stably inserted reporter gene in chicken cells lacking other AID/APOBEC proteins and increases imatinib-resistant clones in a human CML model through BCR-ABL1 mutations.\",\n      \"method\": \"Reporter gene inactivation assay in DT40 chicken cells, imatinib resistance clonogenic assay in human CML cells, sequence analysis of mutations\",\n      \"journal\": \"Genome biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple cell-based functional assays with sequence-level mechanistic evidence\",\n      \"pmids\": [\"25085003\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Genome-wide deep sequencing identifies 56 novel Apobec-1-dependent C-to-U editing sites in intestinal mRNAs and 22 in liver mRNAs, all in 3'UTRs; editing changes lead to corresponding changes in mRNA and protein levels for 11 genes; cell-free editing validated by wild-type but not Apobec-1-deficient mouse extracts.\",\n      \"method\": \"Deep RNA sequencing of wild-type and Apobec-1-/- mice, Sanger validation, polysome profiling, cell-free editing assays, adenoviral rescue, transgenic overexpression\",\n      \"journal\": \"Genome biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genome-wide with multiple validation approaches and mechanistic functional consequences\",\n      \"pmids\": [\"24946870\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"A1CF is dispensable for APOBEC1-mediated C-to-U RNA editing in vivo in adult mice; conditional A1cf knockout mice show no changes in RNA editing efficiency for multiple targets including ApoB in intestine, liver, or kidney.\",\n      \"method\": \"Conditional knockout mice (A1cf floxed allele), RNA editing quantification by sequencing of multiple targets\",\n      \"journal\": \"RNA (New York, N.Y.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean conditional KO with systematic quantification of multiple editing targets\",\n      \"pmids\": [\"28069890\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"APOBEC1-mediated RNA editing in microglia maintains their resting state; loss of APOBEC1 editing function in microglia leads to progressive age-related neurodegeneration characterized by clustering of activated microglia, aberrant myelination, increased inflammation, and lysosomal anomalies with behavioral and motor deficits.\",\n      \"method\": \"APOBEC1 editing-deficient mouse model, histological analysis, behavioral assays, protein abundance analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO with defined neurological phenotype, single lab\",\n      \"pmids\": [\"29167375\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"A1CF and RBM47 function independently yet interact in a tissue-specific manner to regulate APOBEC1-dependent C-to-U RNA editing; intestinal-specific Rbm47 KO nearly eliminates editing while liver-specific Rbm47 KO reduces a subset; double A1cf/Rbm47 KO in liver eliminates apoB editing and eliminates editing of most targets, beyond the effect of either single KO.\",\n      \"method\": \"Tissue-specific conditional knockout mice (liver and intestine), RNA editing quantification, adenoviral APOBEC1 administration\",\n      \"journal\": \"RNA (New York, N.Y.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis with multiple tissue-specific double knockouts, systematic editing quantification\",\n      \"pmids\": [\"30309881\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Crystal structure of APOBEC1 reveals a typical APOBEC deaminase core plus a unique well-folded hydrophobic C-terminal domain (A1HD) that forms a stable dimer via hydrophobic interactions creating a four-stranded β-sheet positively charged surface; structure-guided mutagenesis shows A1HD directs RNA and cofactor interactions and governs RNA versus DNA substrate selectivity.\",\n      \"method\": \"X-ray crystallography, structure-guided mutagenesis, substrate selectivity assays\",\n      \"journal\": \"NAR cancer\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure with mutagenesis validation of functional domains\",\n      \"pmids\": [\"33094286\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"RPA (replication protein A) suppresses APOBEC1 cytosine deaminase activity on ssDNA by competing for ssDNA binding; APOBEC1 cannot efficiently compete with RPA in vitro, correlating with low levels of genomic DNA damage in lung cancer cells expressing APOBEC1.\",\n      \"method\": \"In vitro deamination assays with RPA competition, γH2AX foci measurement in lung cancer cell line\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vitro biochemical assay plus cell-based validation, single lab\",\n      \"pmids\": [\"33330905\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"hnRNPQ isoform 6 (hnRNPQ6) is required for efficient interaction of APOBEC1 with IL-8 mRNA; APOBEC1 binding to AU-rich elements in the IL-8 3'UTR extends IL-8 mRNA half-life and increases IL-8 production in a cell type-specific, hnRNPQ6-dependent manner.\",\n      \"method\": \"RNA co-immunoprecipitation/microarray, mRNA half-life assays, yeast two-hybrid, siRNA screen, luciferase reporter with IL-8 3'UTR\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple assays establishing the hnRNPQ6–APOBEC1–IL8 mRNA ternary interaction, single lab\",\n      \"pmids\": [\"25100733\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"C-to-U RNA editing of neurofibromatosis 1 (NF1) mRNA by APOBEC1 occurs preferentially in transcripts containing alternatively spliced exon 23A; adenovirus-mediated APOBEC1 expression in HepG2 cells induces NF1 transcript editing with preference for exon 23A-containing forms, demonstrating APOBEC1 as the catalytic deaminase for this non-apoB target.\",\n      \"method\": \"In vitro editing assays with recombinant APOBEC1 on synthetic NF1 RNA templates, adenoviral transduction of HepG2 cells, editing quantification by sequencing\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vitro and in vivo reconstitution with adenoviral APOBEC1, single lab\",\n      \"pmids\": [\"11727199\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"APOBEC1 is a zinc-dependent cytidine deaminase that functions as the catalytic subunit of a multiprotein RNA editing complex, converting C6666 to U in apoB mRNA (producing apoB48) and editing dozens of additional mRNA targets in 3'UTRs; it requires RNA-binding cofactors—primarily RBM47 (in vivo) and/or A1CF—which bind the mooring sequence and remodel the RNA stem-loop to expose the target cytidine for deamination, while additional regulators (GRY-RBP, CUGBP2, ABBP-1, ABBP-2/Hsp40) modulate holoenzyme assembly; beyond RNA editing, APOBEC1 stabilizes AU-rich mRNAs (COX-2, c-myc, Cyp7a1, IL-8) through direct 3'UTR binding, and can also deaminate cytosines in single-stranded DNA in a sequence-context-dependent manner that is suppressed by RPA, with the homodimeric structure (mediated by the C-terminal hydrophobic domain) and PKC-mediated phosphorylation of ACF regulating editosome assembly and activity.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"APOBEC1 is a zinc-dependent cytidine deaminase that serves as the catalytic subunit of the apolipoprotein B mRNA editing holoenzyme, converting C6666 to U to produce apoB48, and edits dozens of additional mRNA targets predominantly in 3′ UTRs [PMID:8626621, PMID:21258325, PMID:24946870]. APOBEC1 requires RNA-binding cofactors—RBM47 as the principal in vivo partner and A1CF contributing in a tissue-specific manner—that recognize the mooring sequence and remodel the RNA stem-loop to expose the target cytidine for deamination [PMID:10669759, PMID:24916387, PMID:30309881, PMID:15659357]. Beyond RNA editing, APOBEC1 binds AU-rich elements in 3′ UTRs of mRNAs such as COX-2, c-myc, Cyp7a1, and IL-8, stabilizing them post-transcriptionally through a mechanism dependent on its RNA-binding activity but independent of catalytic editing [PMID:10688645, PMID:15480992, PMID:19386592, PMID:25100733]. APOBEC1 also deaminates cytosines in single-stranded DNA in a sequence-context-dependent manner that is suppressed by RPA binding, and its homodimeric structure—mediated by a unique C-terminal hydrophobic domain—governs substrate selectivity between RNA and DNA [PMID:12697753, PMID:33094286, PMID:33330905].\",\n  \"teleology\": [\n    {\n      \"year\": 1995,\n      \"claim\": \"Defining the catalytic architecture of APOBEC1 established that zinc-coordinating residues (H61, E63, C93, C96) are essential for deaminase activity, a leucine-rich region is required for editing but not deamination, and an RNA-binding domain mediates AU-rich RNA recognition—resolving how a single protein couples substrate binding to catalysis.\",\n      \"evidence\": \"Site-directed mutagenesis of GST-APOBEC1 with in vitro deaminase, UV cross-linking, and EMSA assays in McA 7777 cells\",\n      \"pmids\": [\"7782343\", \"7782342\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No three-dimensional structure available at this stage\", \"Cofactor requirements for site-specific editing not yet defined\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Knockout of Apobec1 in mice abolished all apoB mRNA editing and apoB48 production in every tissue, proving APOBEC1 is the sole essential catalytic subunit with no redundant paralog, while overexpression studies revealed dose-dependent promiscuous editing at additional mooring-sequence-dependent cytidines.\",\n      \"evidence\": \"Gene targeting in mice with apoB editing and protein assays; stable overexpression in rat hepatoma cells with dose-response editing analysis\",\n      \"pmids\": [\"8626621\", \"8824235\", \"8621694\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the obligate cofactor unknown\", \"Mechanism controlling editing fidelity versus promiscuity unresolved\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Demonstration that APOBEC1 functions as a homodimer—with catalytically inactive dimers acting as dominant negatives—and identification of auxiliary binding partners (ABBP-1) established that editosome assembly involves regulated multimerization.\",\n      \"evidence\": \"Co-immunoprecipitation of epitope-tagged mutants, adenoviral delivery to mice, yeast two-hybrid and immunodepletion for ABBP-1\",\n      \"pmids\": [\"8999814\", \"8999813\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of dimerization unknown\", \"Stoichiometry and order of assembly not defined\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Discovery that APOBEC1 binds a UUUN[A/U]U consensus motif in AU-rich 3′ UTRs and stabilizes c-myc mRNA revealed a second, editing-independent function—mRNA stabilization—broadening APOBEC1's biological role beyond site-specific deamination.\",\n      \"evidence\": \"Filter binding, circular-permutation analysis, actinomycin D chase in transfected F442A cells with RNA-binding mutant controls\",\n      \"pmids\": [\"10688645\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full repertoire of stabilized mRNAs unknown\", \"Mechanism distinguishing editing from stabilization unclear\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Identification of ACF as the obligate RNA-binding cofactor that recognizes the mooring sequence and constitutes, with APOBEC1, the minimal editing holoenzyme resolved the long-standing question of what confers site specificity, while GRY-RBP was shown to negatively regulate editing by sequestering ACF.\",\n      \"evidence\": \"Protein purification and peptide sequencing, UV cross-linking, co-IP, immunodepletion, in vitro reconstitution; GRY-RBP identified by two-hybrid with competition and knockdown assays\",\n      \"pmids\": [\"10669759\", \"11134005\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of ACF–APOBEC1 interaction unknown\", \"In vivo requirement of ACF versus other cofactors not tested genetically\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Identification of additional editosome regulators—CUGBP2 as a dose-dependent inhibitor and ABBP-2/Hsp40 as an ATP-dependent activator—demonstrated that the holoenzyme is a dynamically regulated multiprotein assembly, not a simple binary complex; APOBEC1 was also shown to edit NF1 mRNA, extending its target repertoire.\",\n      \"evidence\": \"Co-fractionation, co-IP, reconstituted editing with purified components, antisense knockdown; NF1 editing by adenoviral APOBEC1 in HepG2 cells\",\n      \"pmids\": [\"11577082\", \"11584023\", \"11727199\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Relative contributions of each auxiliary factor in vivo undetermined\", \"NF1 editing not validated in Apobec1 knockout mice\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Demonstration that APOBEC1 deaminates cytosines in single-stranded DNA in a sequence-context-dependent manner established it as a dual RNA/DNA deaminase, raising the possibility of genomic mutagenesis.\",\n      \"evidence\": \"In vitro deamination assay with partially purified APOBEC1 on ssDNA substrates; confirmed in E. coli rifampicin-resistance mutation assay\",\n      \"pmids\": [\"12697753\", \"12453430\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo relevance of DNA deamination in mammalian cells not yet shown\", \"No structural explanation for dual substrate activity\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"NMR structure of the apoB mRNA stem-loop showed that C6666 is buried in the loop, and ACF melts the stem-loop to expose the target cytidine, providing the first structural mechanism for how cofactor-mediated RNA remodeling enables site-specific editing.\",\n      \"evidence\": \"NMR structure determination of 31-nt apoB RNA, binding assays with APOBEC1 ± ACF\",\n      \"pmids\": [\"15659357\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No co-crystal structure of the ternary APOBEC1–ACF–RNA complex\", \"Kinetic mechanism of stem-loop melting not characterized\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"PKC-mediated phosphorylation of ACF at S154 and S368 was shown to regulate editosome assembly and ethanol-stimulated editing, providing a signal transduction mechanism that modulates APOBEC1 activity in response to metabolic cues.\",\n      \"evidence\": \"In vitro kinase assays, phosphomimetic and phosphodead mutagenesis, editing assays in primary hepatocytes\",\n      \"pmids\": [\"16820530\", \"17229474\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Upstream signaling pathway linking ethanol to PKC activation not fully defined\", \"Whether phosphorylation regulates ACF shuttling is unknown\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Transcriptome-wide RNA-Seq revealed dozens of novel APOBEC1-dependent C-to-U editing sites, all in 3′ UTR AU-rich regions, and APOBEC1 was shown to restrict LINE-1 and LTR retrotransposition through partially deamination-independent mechanisms, expanding its functional scope beyond mRNA editing.\",\n      \"evidence\": \"Comparative RNA-Seq of APOBEC1-expressing vs. control cells with Sanger validation; cell-based retrotransposition assays with catalytic mutants\",\n      \"pmids\": [\"21258325\", \"21398638\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional consequences of most 3′ UTR editing events unknown\", \"Deamination-independent retrotransposon restriction mechanism undefined\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Identification of RBM47 as a cofactor that is necessary and sufficient for APOBEC1-mediated editing in vivo, and demonstration that APOBEC1 induces genomic DNA mutations in vertebrate cells, resolved two key questions: the in vivo cofactor identity and whether DNA deamination has physiological mutagenic consequences.\",\n      \"evidence\": \"Rbm47 KO mice with editing quantification plus in vitro reconstitution; reporter gene inactivation in DT40 cells and imatinib resistance assay in CML cells\",\n      \"pmids\": [\"24916387\", \"25085003\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contribution of RBM47 vs. A1CF across tissues not resolved at this point\", \"Frequency and spectrum of APOBEC1-induced DNA mutations in normal tissues unknown\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Conditional A1cf knockout mice showed no editing deficiency, demonstrating A1CF is dispensable in vivo, while loss of APOBEC1 editing function in microglia caused progressive neurodegeneration—revealing an unexpected role in maintaining microglial homeostasis.\",\n      \"evidence\": \"Conditional A1cf KO with systematic editing quantification; APOBEC1 editing-deficient mouse model with histological, behavioral, and inflammatory readouts\",\n      \"pmids\": [\"28069890\", \"29167375\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific mRNA targets mediating the microglial phenotype not identified\", \"Whether RBM47 fully compensates for A1CF loss in all contexts unclear\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Genetic epistasis with tissue-specific double knockouts of A1cf and Rbm47 demonstrated that these cofactors function independently but collaborate in a tissue-specific manner, with the double KO eliminating apoB editing in liver—clarifying the cofactor hierarchy.\",\n      \"evidence\": \"Tissue-specific conditional KO mice (liver and intestine) with systematic RNA editing quantification\",\n      \"pmids\": [\"30309881\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of RBM47 vs. A1CF preference for different editing sites unknown\", \"Mechanistic basis of tissue-specific cofactor utilization not defined\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"The crystal structure of APOBEC1 revealed a unique C-terminal hydrophobic domain (A1HD) that mediates stable dimerization and forms a positively charged β-sheet surface that directs RNA versus DNA substrate selectivity and cofactor interactions, finally providing structural explanations for dimerization and dual substrate activity.\",\n      \"evidence\": \"X-ray crystallography with structure-guided mutagenesis and substrate selectivity assays\",\n      \"pmids\": [\"33094286\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No structure of APOBEC1 in complex with ACF/RBM47 or RNA substrate\", \"Conformational dynamics during catalysis not captured\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"RPA was shown to suppress APOBEC1 DNA deamination activity by outcompeting it for ssDNA binding, providing a mechanistic explanation for why APOBEC1 expression causes limited genomic damage despite its intrinsic DNA mutator activity.\",\n      \"evidence\": \"In vitro deamination assays with RPA competition; γH2AX foci measurement in lung cancer cells\",\n      \"pmids\": [\"33330905\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vivo validation of RPA protection against APOBEC1-mediated mutagenesis lacking\", \"Whether replication stress or RPA depletion unmasks APOBEC1 DNA damage in physiological settings is untested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"A high-resolution structure of the complete APOBEC1–RBM47(or A1CF)–RNA ternary complex is needed to understand how cofactor binding remodels the RNA substrate and positions the target cytidine in the active site, and the physiological significance of APOBEC1-mediated DNA deamination in normal somatic tissues remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No ternary complex structure available\", \"In vivo contribution of APOBEC1 to somatic mutagenesis in healthy tissues unknown\", \"Full functional consequences of 3′ UTR editing on mRNA fate and translation not systematically characterized\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140098\", \"supporting_discovery_ids\": [0, 2, 3, 8, 22, 27, 31]},\n      {\"term_id\": \"GO:0140097\", \"supporting_discovery_ids\": [15, 17, 30]},\n      {\"term_id\": \"GO:0003723\", \"supporting_discovery_ids\": [1, 7, 20, 26]},\n      {\"term_id\": \"GO:0016787\", \"supporting_discovery_ids\": [0, 17]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [10, 14, 25]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [10, 25]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-8953854\", \"supporting_discovery_ids\": [2, 8, 22, 27, 31, 34]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [26]}\n    ],\n    \"complexes\": [\n      \"apoB mRNA editosome\"\n    ],\n    \"partners\": [\n      \"A1CF\",\n      \"RBM47\",\n      \"CUGBP2\",\n      \"GRY-RBP\",\n      \"ABBP-1\",\n      \"DNAJB1\",\n      \"SYNCRIP\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}